Authors
Loading...
Randomized trial finds that monoclonal antibody treatment boosts CD4 T-cell responses in ABLV-infected mice, suggesting improved therapeutic approaches.
Huaman et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: